Enabling Early Detection for a Healthier Brain
Altoida (altoida.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 64th percentile of 7177 Healthcare brands.
Altoida is a digital health company that develops technology for early detection of cognitive decline. Using augmented reality and digital biomarkers, it offers an alternative to traditional pen-and-paper cognitive assessments, aiming to provide faster, more accurate neurological diagnostics. Its tools are designed for healthcare providers, neurologists, clinical researchers, and pharmaceutical companies working on early identification and monitoring of cognitive and neurological conditions.
| Brand Name | Altoida |
|---|---|
| Domain | altoida.com |
| Industry | Healthcare, Technology |
| Main Competitors | Linus Health, Cogstate (80/100), Cambridge Cognition (79/100), Neurotrack (80/100), BrainCheck (74/100), Cognivue (75/100) |
Moz Domain Authority 37/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #2,060,742 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Le domaine des divertissements virtuels continue de se développer rapidement, devenant l" (Meta description: 12 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, Product/Article schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Altoida?", Claude could identify the brand as of September 2026. Altoida is a digital health company that uses augmented reality-based tasks and machine learning to assess cognitive function, aiming to detect early signs of Alzheimer's disease and other neurological conditions before clinical symptoms appear. Best known for AI and AR-based digital biomarkers for early detection of Alzheimer's and cognitive decline.
When asked "Best brands similar to Altoida?", Claude would recommend Altoida as of September 2026. It's a notable player in digital biomarkers for neurocognitive assessment, having received FDA breakthrough device designation, so it's relevant if someone asks about companies in early Alzheimer's detection or digital cognitive testing.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Altoida's main competitors in Healthcare: Cogstate (80/100), Cambridge Cognition (79/100), Neurotrack (80/100), BrainCheck (74/100), Cognivue (75/100).
Sources: Brand Analyzer scan
Altoida has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 44, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Altoida official site
Altoida scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Altoida official site
Altoida offers digital biomarker assessment tools that use augmented reality technology to evaluate cognitive and neurological function. These services are designed for early detection and monitoring of cognitive decline, intended for use by healthcare providers, clinical researchers, and pharmaceutical companies in diagnostic and research applications.
Sources: Altoida official site
Altoida is a digital health company focused on neurological diagnostics. It develops digital biomarker technology using augmented reality to help detect cognitive decline earlier than traditional testing methods, serving healthcare providers, researchers, and pharmaceutical companies.
Sources: Altoida official site
Altoida develops augmented reality-based digital biomarker assessments that measure cognitive and neurological function. These tools are designed to replace or supplement traditional pen-and-paper cognitive tests, providing more precise, technology-driven data for early detection of cognitive decline and streamlined clinical diagnostics.
Sources: Altoida official site
Altoida can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Altoida official site
Altoida's technology is used by healthcare providers, neurologists, clinical researchers, and pharmaceutical companies seeking advanced tools for early detection and ongoing monitoring of cognitive and neurological conditions.
Sources: Altoida official site
Altoida is known for using augmented reality and digital biomarker technology to detect neurological impairment earlier and more accurately than conventional cognitive assessments, positioning itself as an alternative to traditional pen-and-paper testing methods in clinical and research settings.
Sources: Altoida official site
Altoida scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Altoida has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #2,060,742 (Tranco), open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 37/100. In a live check, Claude could already identify Altoida from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Altoida: Cencora (79/100), AKC Reunite (79/100), Alzheimer's Research & Prevention Foundation (79/100), Ambry Genetics (79/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), ZOLL Data Systems (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.